Amarin Corp Plcuk (AMRN) Equity Ratio (2010 - 2026)

Amarin Corp Plcuk (AMRN) reported Equity Ratio of 0.7 for Q1 2026, down 3.66% year-over-year from 0.72 in Q1 2025, and up 1.64% quarter-over-quarter from 0.68 in Q4 2025.

Amarin Corp Plcuk (AMRN) Equity Ratio (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 17 years of Equity Ratio data on file, last reported at 0.7 in Q1 2026.

  • Equity Ratio for Q1 2026 came in at 0.7, down 3.66% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.7 (down 3.66% YoY), and the FY2025 annual result was 0.68, down 3.48% from the prior year.
  • Equity Ratio rose to 0.7 in Q1 2026 per AMRN's latest filing, from 0.68 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.72 in Q1 2025 and troughed at 0.6 in Q2 2022.
  • A 5-year average of 0.68 and a median of 0.68 in 2025 frame the typical range for Equity Ratio.
  • The sharpest annual moves came in 2023 and 2026: Equity Ratio rose 11.04% in 2023, then dropped 3.66% in 2026.
  • A 5-year view of Equity Ratio shows it stood at 0.67 in 2022, then declined by 1.19% to 0.66 in 2023, then increased by 6.86% to 0.71 in 2024, then retreated by 3.48% to 0.68 in 2025, then climbed by 1.64% to 0.7 in 2026.
  • Business Quant data shows AMRN's Equity Ratio at 0.7 in Q1 2026, 0.68 in Q4 2025, and 0.7 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 0.27
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 0.40
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -0.05
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 0.36
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 0.10
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 0.42
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 0.43
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 0.23
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn 0.70

Historic Data

Download Data
DateValue
Mar 31, 2026 0.70
Dec 31, 2025 0.68
Sep 30, 2025 0.70
Jun 30, 2025 0.69
Mar 31, 2025 0.72
Dec 31, 2024 0.71
Sep 30, 2024 0.71
Jun 30, 2024 0.69
Mar 31, 2024 0.69
Dec 31, 2023 0.66
Sep 30, 2023 0.66
Jun 30, 2023 0.66
Mar 31, 2023 0.68
Dec 31, 2022 0.67
Sep 30, 2022 0.65
Jun 30, 2022 0.60
Mar 31, 2022 0.66
Dec 31, 2021 0.62
Sep 30, 2021 0.62
Jun 30, 2021 0.62